No ASXL1+ cases presented complex karyotypes or other myelodysplastic syndrome‐related cytogenetic abnormalities, thus suggesting that both findings might be mutually exclusive and redundant from a pathophysiological point of view. Also the ASXL1 mutation showed a negative correlation with the TP53 mutation. The gene discussed is TP53; the disease is myelodysplastic syndrome.